EQT Life Sciences and LSP 7 Lead $56M Series D in Neuros Medical

EQT Acquires LSP (Life Sciences Partners)

November 10, 2021

Financial Services

EQT AB has acquired LSP (Life Sciences Partners), a leading European life-sciences venture capital firm, in a transaction that creates a new EQT Life Sciences business line. The deal values the upfront consideration at EUR 450 million (25% cash / 75% EQT shares) with a EUR 25 million earn‑out paid on meeting fundraising targets (total consideration EUR 475 million at close); LSP's 34-person team and partners join EQT to strengthen its healthcare investing capabilities.

EQT Life Sciences and Gimv Co-Lead €51M Series B in Exciva

January 20, 2026

Biotechnology

EQT Life Sciences (via its LSP Dementia Fund) and Gimv co-led a €51 million Series B in German clinical-stage biopharmaceutical company Exciva to fund a Phase 2 trial of its lead candidate, Deraphan, for agitation associated with Alzheimer's disease. Additional participants included Fountain Healthcare Partners, LifeArc, Carma Fund, Modi Ventures, Andera Partners, LBBW and returning investors; proceeds will support multinational Phase 2 studies across the EU, United States and Canada.

Public Pension Capital Invests in Life Science Outsourcing, Inc.

January 25, 2021

Medical Devices

Public Pension Capital, a New York-based private equity fund, made an investment in Life Science Outsourcing, Inc., a Brea, California-based contract manufacturer serving medical device companies. The transaction, completed January 25, 2021, will support LSO's medical package testing, validation, sterilization and distribution services and help accelerate the company's growth and capacity to serve device startups and larger OEMs.

EQT Future and ATHOS Lead Minority Investment in SHL Medical

December 9, 2022

Medical Devices

EQT Future, ATHOS and other co-investors have acquired a minority stake in SHL Medical from EQT's Equity fund VIII, with founder Roger Samuelsson remaining the majority shareholder. The consortium will support SHL Medical's next growth phase — expanding production into the United States and Europe, launching new product platforms, and advancing sustainability and circularity initiatives.

EQT Private Equity Acquires SPT Labtech from Battery Ventures for GBP 650 million

June 22, 2022

Medical Devices

EQT Private Equity (EQT IX) has agreed to acquire SPT Labtech, a UK-based designer and manufacturer of automated liquid handling, sample preparation and consumables for life science research, from Battery Ventures for GBP 650 million. EQT will support SPT's next phase of growth by accelerating product innovation, scaling its Cryo-EM sample preparation business and expanding into new geographies and end markets; the transaction is expected to close in Q3 2022.

Concord Health Partners Leads Growth Financing in Accelus

May 29, 2025

Medical Devices

Accelus, a Palm Beach Gardens-based medical technology company specializing in expandable spinal implant technologies, closed a new equity financing round led by healthcare-focused investment firm Concord Health Partners. The capital will support Accelus's U.S. commercial expansion and further development of its spinal implant product pipeline.